Weiss Multi-Strategy Advisers’s Fusion Pharmaceuticals FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-172,357
Closed -$1.66M – 518
2023
Q4
$1.66M Buy
+172,357
New +$837K 0.04% 390

Other funds holding FUSN

Weiss Multi-Strategy Advisers's FUSN Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Fusion Pharmaceuticals (FUSN) in Q1 2024, closing a stake of 172,357 shares — an estimated $1.66M sold.

Weiss Multi-Strategy Advisers first reported a position in FUSN in Q4 2023 and held it in 1 quarter. The position peaked at $1.66M in Q4 2023. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Fusion Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 172,357 Fusion Pharmaceuticals shares in Q1 2024, an estimated $1.66M.
  • Weiss Multi-Strategy Advisers first reported a position in Fusion Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Fusion Pharmaceuticals position peaked at $1.66M in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.